Skip to main content
Top
Published in: International Urology and Nephrology 1/2015

01-01-2015 | Nephrology - Original Paper

Peritoneal microvascular endothelial function and the microinflammatory state are associated with baseline peritoneal transport characteristics in uremic patients

Authors: Lanbo Teng, Ming Chang, Shuxin Liu, Min Niu, Yungang Zhang, Xiangfei Liu, Xiaoxia Yu

Published in: International Urology and Nephrology | Issue 1/2015

Login to get access

Abstract

Purpose

To investigate microvessel density (MVD), vascular endothelial growth factor (VEGF), endothelial nitric oxide synthase (eNOS), and interleukin-6 (IL-6) mRNA expression in peritoneal tissues, and their relationships with baseline peritoneal transport in uremia.

Methods

Thirty uremic patients with a peritoneal dialysis catheter were selected in the Department of Nephrology in Dalian Central Hospital, Liaoning, China between 2010 and 2012. Peritoneal specimens were harvested for assessment of MVD, VEGF, eNOS, and IL-6 mRNA expression. One month after continuous ambulatory peritoneal dialysis, a peritoneal equilibration test was conducted. According to the 4-h peritoneal dialysate and plasma creatinine ratio (D/P Cr), patients were divided into high (n = 16) and low (n = 14) transport groups.

Results

General clinical data of high and low transport groups were similar (P > 0.05). The MVD in peritoneal tissues was significantly higher in the high than in the low transport group (P < 0.05). Correspondingly, VEGF (P < 0.01), eNOS (P < 0.01), and IL-6 (P < 0.05) mRNA expression levels were significantly higher in the high as compared the low transport groups. Correlation analysis showed that the baseline D/P Cr was positively correlated with MVD and VEGF, eNOS, and IL-6 mRNA expression levels in the peritoneum (r = 0.506, 0.646, 0.638, and 0.686, respectively; P < 0.01).

Conclusions

Uremic patients display differences in peritoneal microvascular endothelial function and microinflammatory states before peritoneal dialysis. Patients of the high transport group have higher MVD, increased expression of endothelial function markers (VEGF and eNOS), and the microinflammatory marker (IL-6). These observations are closely related to high baseline peritoneal transport.
Literature
1.
go back to reference Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D (1998) Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9:1285–1292PubMed Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D (1998) Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9:1285–1292PubMed
2.
go back to reference Flessner MF (1996) Small-solute transport across specific peritoneal tissue surfaces in the rat. J Am Soc Nephrol 7:225–233PubMed Flessner MF (1996) Small-solute transport across specific peritoneal tissue surfaces in the rat. J Am Soc Nephrol 7:225–233PubMed
4.
go back to reference Rodrigues AS, Almeida M, Fonseca I, Martins M, Carvalho MJ, Silva F, Correia C, Santos MJ, Cabrita A (2006) Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation. Nephrol Dial Transplant 21:763–769. doi:10.1093/ndt/gfi245 PubMedCrossRef Rodrigues AS, Almeida M, Fonseca I, Martins M, Carvalho MJ, Silva F, Correia C, Santos MJ, Cabrita A (2006) Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation. Nephrol Dial Transplant 21:763–769. doi:10.​1093/​ndt/​gfi245 PubMedCrossRef
5.
go back to reference Rodrigues AS, Martins M, Korevaar JC, Silva S, Oliveira JC, Cabrita A, Castro e Melo J, Krediet RT (2007) Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters. Am J Nephrol 27:84–91. doi:10.1159/000099332 PubMedCrossRef Rodrigues AS, Martins M, Korevaar JC, Silva S, Oliveira JC, Cabrita A, Castro e Melo J, Krediet RT (2007) Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters. Am J Nephrol 27:84–91. doi:10.​1159/​000099332 PubMedCrossRef
6.
go back to reference Margetts PJ, McMullin JP, Rabbat CG, Churchill DN (2000) Peritoneal membrane transport and hypoalbuminemia: cause or effect? Perit Dial Int 20:14–18PubMed Margetts PJ, McMullin JP, Rabbat CG, Churchill DN (2000) Peritoneal membrane transport and hypoalbuminemia: cause or effect? Perit Dial Int 20:14–18PubMed
7.
go back to reference Oh KH, Jung JY, Yoon MO, Song A, Lee H, Ro H, Hwang YH, Kim DK, Margetts P, Ahn C (2010) Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients. Nephrol Dial Transplant 25:1639–1646. doi:10.1093/ndt/gfp670 PubMedCrossRef Oh KH, Jung JY, Yoon MO, Song A, Lee H, Ro H, Hwang YH, Kim DK, Margetts P, Ahn C (2010) Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients. Nephrol Dial Transplant 25:1639–1646. doi:10.​1093/​ndt/​gfp670 PubMedCrossRef
8.
go back to reference Hwang YH, Son MJ, Yang J, Kim K, Chung W, Joo KW, Kim Y, Ahn C, Oh KH (2009) Effects of interleukin-6 T15A single nucleotide polymorphism on baseline peritoneal solute transport rate in incident peritoneal dialysis patients. Perit Dial Int 29:81–88PubMed Hwang YH, Son MJ, Yang J, Kim K, Chung W, Joo KW, Kim Y, Ahn C, Oh KH (2009) Effects of interleukin-6 T15A single nucleotide polymorphism on baseline peritoneal solute transport rate in incident peritoneal dialysis patients. Perit Dial Int 29:81–88PubMed
9.
go back to reference Wong TY, Szeto CC, Szeto CY, Lai KB, Chow KM, Li PK (2003) Association of ENOS polymorphism with basal peritoneal membrane function in uremic patients. Am J Kidney Dis 42:781–786PubMedCrossRef Wong TY, Szeto CC, Szeto CY, Lai KB, Chow KM, Li PK (2003) Association of ENOS polymorphism with basal peritoneal membrane function in uremic patients. Am J Kidney Dis 42:781–786PubMedCrossRef
12.
go back to reference Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW (2004) Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis 43:492–501PubMedCrossRef Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW (2004) Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis 43:492–501PubMedCrossRef
13.
go back to reference Zhang AHFLWG (2010) Association between pre-dialysis peritoneal microvascular density and baseline peritoneal solute transport status. Chin J Blood Purif 10:554–557 Zhang AHFLWG (2010) Association between pre-dialysis peritoneal microvascular density and baseline peritoneal solute transport status. Chin J Blood Purif 10:554–557
14.
go back to reference Combet S, Miyata T, Moulin P, Pouthier D, Goffin E, Devuyst O (2000) Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 11:717–728PubMed Combet S, Miyata T, Moulin P, Pouthier D, Goffin E, Devuyst O (2000) Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 11:717–728PubMed
15.
go back to reference Noh H, Kim JS, Han KH, Lee GT, Song JS, Chung SH, Jeon JS, Ha H, Lee HB (2006) Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int 69:2022–2028. doi:10.1038/sj.ki.5001506 PubMedCrossRef Noh H, Kim JS, Han KH, Lee GT, Song JS, Chung SH, Jeon JS, Ha H, Lee HB (2006) Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int 69:2022–2028. doi:10.​1038/​sj.​ki.​5001506 PubMedCrossRef
16.
go back to reference Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364PubMedCrossRef Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364PubMedCrossRef
17.
go back to reference Lopez-Cabrera M, Aguilera A, Aroeira LS, Ramirez-Huesca M, Perez-Lozano ML, Jimenez-Heffernan JA, Bajo MA, del Peso G, Sanchez-Tomero JA, Selgas R (2006) Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure. Perit Dial Int 26:26–34PubMed Lopez-Cabrera M, Aguilera A, Aroeira LS, Ramirez-Huesca M, Perez-Lozano ML, Jimenez-Heffernan JA, Bajo MA, del Peso G, Sanchez-Tomero JA, Selgas R (2006) Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure. Perit Dial Int 26:26–34PubMed
18.
go back to reference Ku DD, Zaleski JK, Liu S, Brock TA (1993) Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265:H586–H592PubMed Ku DD, Zaleski JK, Liu S, Brock TA (1993) Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265:H586–H592PubMed
19.
go back to reference de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH (2001) Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12:993–1000PubMed de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH (2001) Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12:993–1000PubMed
21.
22.
go back to reference Kubes P (1995) Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 2:235–244PubMedCrossRef Kubes P (1995) Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 2:235–244PubMedCrossRef
23.
24.
go back to reference Zweers MM, de Waart DR, Smit W, Struijk DG, Krediet RT (1999) Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med 134:124–132PubMedCrossRef Zweers MM, de Waart DR, Smit W, Struijk DG, Krediet RT (1999) Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med 134:124–132PubMedCrossRef
25.
go back to reference Zareie M, De Vriese AS, Hekking LH, ter Wee PM, Schalkwijk CG, Driesprong BA, Schadee-Eestermans IL, Beelen RH, Lameire N, van den Born J (2005) Immunopathological changes in a uraemic rat model for peritoneal dialysis. Nephrol Dial Transplant 20:1350–1361. doi:10.1093/ndt/gfh835 PubMedCrossRef Zareie M, De Vriese AS, Hekking LH, ter Wee PM, Schalkwijk CG, Driesprong BA, Schadee-Eestermans IL, Beelen RH, Lameire N, van den Born J (2005) Immunopathological changes in a uraemic rat model for peritoneal dialysis. Nephrol Dial Transplant 20:1350–1361. doi:10.​1093/​ndt/​gfh835 PubMedCrossRef
26.
go back to reference Pecoits-Filho R, Araujo MR, Lindholm B, Stenvinkel P, Abensur H, Romao JE Jr, Marcondes M, De Oliveira AH, Noronha IL (2002) Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 17:1480–1486PubMedCrossRef Pecoits-Filho R, Araujo MR, Lindholm B, Stenvinkel P, Abensur H, Romao JE Jr, Marcondes M, De Oliveira AH, Noronha IL (2002) Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 17:1480–1486PubMedCrossRef
27.
go back to reference Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, Gewertz BL (1999) Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol 277:L1057–L1065PubMed Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, Gewertz BL (1999) Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol 277:L1057–L1065PubMed
29.
go back to reference Gillerot G, Goffin E, Michel C, Evenepoel P, Biesen WV, Tintillier M, Stenvinkel P, Heimburger O, Lindholm B, Nordfors L, Robert A, Devuyst O (2005) Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 67:2477–2487. doi:10.1111/j.1523-1755.2005.00357.x PubMedCrossRef Gillerot G, Goffin E, Michel C, Evenepoel P, Biesen WV, Tintillier M, Stenvinkel P, Heimburger O, Lindholm B, Nordfors L, Robert A, Devuyst O (2005) Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 67:2477–2487. doi:10.​1111/​j.​1523-1755.​2005.​00357.​x PubMedCrossRef
Metadata
Title
Peritoneal microvascular endothelial function and the microinflammatory state are associated with baseline peritoneal transport characteristics in uremic patients
Authors
Lanbo Teng
Ming Chang
Shuxin Liu
Min Niu
Yungang Zhang
Xiangfei Liu
Xiaoxia Yu
Publication date
01-01-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0775-1

Other articles of this Issue 1/2015

International Urology and Nephrology 1/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.